Inactivated Polio Vaccine Market
1 Study Coverage
1.1 Inactivated Polio Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Inactivated Polio Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Government
1.2.3 Private Sector
1.3 Market by Application
1.3.1 Global Inactivated Polio Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pediatrics
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inactivated Polio Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Inactivated Polio Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Inactivated Polio Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inactivated Polio Vaccine Sales by Region
2.4.1 Global Inactivated Polio Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Inactivated Polio Vaccine by Region (2023-2028)
2.5 Global Inactivated Polio Vaccine Revenue by Region
2.5.1 Global Inactivated Polio Vaccine Revenue by Region (2017-2022)
2.5.2 Global Inactivated Polio Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inactivated Polio Vaccine Sales by Manufacturers
3.1.1 Global Top Inactivated Polio Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inactivated Polio Vaccine in 2021
3.2 Global Inactivated Polio Vaccine Revenue by Manufacturers
3.2.1 Global Inactivated Polio Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inactivated Polio Vaccine Revenue in 2021
3.3 Global Inactivated Polio Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inactivated Polio Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inactivated Polio Vaccine Sales by Type
4.1.1 Global Inactivated Polio Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Inactivated Polio Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Inactivated Polio Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Inactivated Polio Vaccine Revenue by Type
4.2.1 Global Inactivated Polio Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Inactivated Polio Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Inactivated Polio Vaccine Price by Type
4.3.1 Global Inactivated Polio Vaccine Price by Type (2017-2022)
4.3.2 Global Inactivated Polio Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Inactivated Polio Vaccine Sales by Application
5.1.1 Global Inactivated Polio Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Inactivated Polio Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Inactivated Polio Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Inactivated Polio Vaccine Revenue by Application
5.2.1 Global Inactivated Polio Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Inactivated Polio Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Inactivated Polio Vaccine Price by Application
5.3.1 Global Inactivated Polio Vaccine Price by Application (2017-2022)
5.3.2 Global Inactivated Polio Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Inactivated Polio Vaccine Market Size by Type
6.1.1 North America Inactivated Polio Vaccine Sales by Type (2017-2028)
6.1.2 North America Inactivated Polio Vaccine Revenue by Type (2017-2028)
6.2 North America Inactivated Polio Vaccine Market Size by Application
6.2.1 North America Inactivated Polio Vaccine Sales by Application (2017-2028)
6.2.2 North America Inactivated Polio Vaccine Revenue by Application (2017-2028)
6.3 North America Inactivated Polio Vaccine Market Size by Country
6.3.1 North America Inactivated Polio Vaccine Sales by Country (2017-2028)
6.3.2 North America Inactivated Polio Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Inactivated Polio Vaccine Market Size by Type
7.1.1 Europe Inactivated Polio Vaccine Sales by Type (2017-2028)
7.1.2 Europe Inactivated Polio Vaccine Revenue by Type (2017-2028)
7.2 Europe Inactivated Polio Vaccine Market Size by Application
7.2.1 Europe Inactivated Polio Vaccine Sales by Application (2017-2028)
7.2.2 Europe Inactivated Polio Vaccine Revenue by Application (2017-2028)
7.3 Europe Inactivated Polio Vaccine Market Size by Country
7.3.1 Europe Inactivated Polio Vaccine Sales by Country (2017-2028)
7.3.2 Europe Inactivated Polio Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inactivated Polio Vaccine Market Size by Type
8.1.1 Asia Pacific Inactivated Polio Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Inactivated Polio Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Inactivated Polio Vaccine Market Size by Application
8.2.1 Asia Pacific Inactivated Polio Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Inactivated Polio Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Inactivated Polio Vaccine Market Size by Region
8.3.1 Asia Pacific Inactivated Polio Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Inactivated Polio Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Inactivated Polio Vaccine Market Size by Type
9.1.1 Latin America Inactivated Polio Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Inactivated Polio Vaccine Revenue by Type (2017-2028)
9.2 Latin America Inactivated Polio Vaccine Market Size by Application
9.2.1 Latin America Inactivated Polio Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Inactivated Polio Vaccine Revenue by Application (2017-2028)
9.3 Latin America Inactivated Polio Vaccine Market Size by Country
9.3.1 Latin America Inactivated Polio Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Inactivated Polio Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Inactivated Polio Vaccine Market Size by Type
10.1.1 Middle East and Africa Inactivated Polio Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Inactivated Polio Vaccine Market Size by Application
10.2.1 Middle East and Africa Inactivated Polio Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Inactivated Polio Vaccine Market Size by Country
10.3.1 Middle East and Africa Inactivated Polio Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Corporation Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bibcol Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Corporation Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Serum Institute Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Corporation Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tiantan Biological Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 Panacea Biotec
11.6.1 Panacea Biotec Corporation Information
11.6.2 Panacea Biotec Overview
11.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Panacea Biotec Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Panacea Biotec Recent Developments
11.7 Bio-Med
11.7.1 Bio-Med Corporation Information
11.7.2 Bio-Med Overview
11.7.3 Bio-Med Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bio-Med Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bio-Med Recent Developments
11.8 Halfkin Bio-Pharmaceuticals
11.8.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.8.2 Halfkin Bio-Pharmaceuticals Overview
11.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inactivated Polio Vaccine Industry Chain Analysis
12.2 Inactivated Polio Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inactivated Polio Vaccine Production Mode & Process
12.4 Inactivated Polio Vaccine Sales and Marketing
12.4.1 Inactivated Polio Vaccine Sales Channels
12.4.2 Inactivated Polio Vaccine Distributors
12.5 Inactivated Polio Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inactivated Polio Vaccine Industry Trends
13.2 Inactivated Polio Vaccine Market Drivers
13.3 Inactivated Polio Vaccine Market Challenges
13.4 Inactivated Polio Vaccine Market Restraints
14 Key Findings in The Global Inactivated Polio Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Inactivated Polio Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Government
Table 3. Major Manufacturers of Private Sector
Table 4. Global Inactivated Polio Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Inactivated Polio Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Inactivated Polio Vaccine Sales by Region (2017-2022) & (K Units)
Table 7. Global Inactivated Polio Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Inactivated Polio Vaccine Sales by Region (2023-2028) & (K Units)
Table 9. Global Inactivated Polio Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Inactivated Polio Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Inactivated Polio Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Inactivated Polio Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Inactivated Polio Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Inactivated Polio Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Inactivated Polio Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Inactivated Polio Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Inactivated Polio Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Inactivated Polio Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Inactivated Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Inactivated Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2021)
Table 21. Inactivated Polio Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Inactivated Polio Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Inactivated Polio Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Inactivated Polio Vaccine Sales by Type (2017-2022) & (K Units)
Table 26. Global Inactivated Polio Vaccine Sales by Type (2023-2028) & (K Units)
Table 27. Global Inactivated Polio Vaccine Sales Share by Type (2017-2022)
Table 28. Global Inactivated Polio Vaccine Sales Share by Type (2023-2028)
Table 29. Global Inactivated Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Inactivated Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Inactivated Polio Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Inactivated Polio Vaccine Revenue Share by Type (2023-2028)
Table 33. Inactivated Polio Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Inactivated Polio Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Inactivated Polio Vaccine Sales by Application (2017-2022) & (K Units)
Table 36. Global Inactivated Polio Vaccine Sales by Application (2023-2028) & (K Units)
Table 37. Global Inactivated Polio Vaccine Sales Share by Application (2017-2022)
Table 38. Global Inactivated Polio Vaccine Sales Share by Application (2023-2028)
Table 39. Global Inactivated Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Inactivated Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Inactivated Polio Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Inactivated Polio Vaccine Revenue Share by Application (2023-2028)
Table 43. Inactivated Polio Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Inactivated Polio Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Inactivated Polio Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. North America Inactivated Polio Vaccine Sales by Type (2023-2028) & (K Units)
Table 47. North America Inactivated Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Inactivated Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Inactivated Polio Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. North America Inactivated Polio Vaccine Sales by Application (2023-2028) & (K Units)
Table 51. North America Inactivated Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Inactivated Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Inactivated Polio Vaccine Sales by Country (2017-2022) & (K Units)
Table 54. North America Inactivated Polio Vaccine Sales by Country (2023-2028) & (K Units)
Table 55. North America Inactivated Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Inactivated Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Inactivated Polio Vaccine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Inactivated Polio Vaccine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Inactivated Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Inactivated Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Inactivated Polio Vaccine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Inactivated Polio Vaccine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Inactivated Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Inactivated Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Inactivated Polio Vaccine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Inactivated Polio Vaccine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Inactivated Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Inactivated Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Inactivated Polio Vaccine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Inactivated Polio Vaccine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Inactivated Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Inactivated Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Inactivated Polio Vaccine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Inactivated Polio Vaccine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Inactivated Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Inactivated Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Inactivated Polio Vaccine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Inactivated Polio Vaccine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Inactivated Polio Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Inactivated Polio Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Inactivated Polio Vaccine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Inactivated Polio Vaccine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Inactivated Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Inactivated Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Inactivated Polio Vaccine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Inactivated Polio Vaccine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Inactivated Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Inactivated Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Inactivated Polio Vaccine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Inactivated Polio Vaccine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Inactivated Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Inactivated Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Inactivated Polio Vaccine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Inactivated Polio Vaccine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Inactivated Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Inactivated Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Inactivated Polio Vaccine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Inactivated Polio Vaccine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Inactivated Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Inactivated Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Inactivated Polio Vaccine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Inactivated Polio Vaccine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Inactivated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Sanofi Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Sanofi Recent Developments
Table 110. GSK Corporation Information
Table 111. GSK Description and Major Businesses
Table 112. GSK Inactivated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. GSK Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GSK Recent Developments
Table 115. Bibcol Corporation Information
Table 116. Bibcol Description and Major Businesses
Table 117. Bibcol Inactivated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Bibcol Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bibcol Recent Developments
Table 120. Serum Institute Corporation Information
Table 121. Serum Institute Description and Major Businesses
Table 122. Serum Institute Inactivated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Serum Institute Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Serum Institute Recent Developments
Table 125. Tiantan Biological Corporation Information
Table 126. Tiantan Biological Description and Major Businesses
Table 127. Tiantan Biological Inactivated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Tiantan Biological Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Tiantan Biological Recent Developments
Table 130. Panacea Biotec Corporation Information
Table 131. Panacea Biotec Description and Major Businesses
Table 132. Panacea Biotec Inactivated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Panacea Biotec Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Panacea Biotec Recent Developments
Table 135. Bio-Med Corporation Information
Table 136. Bio-Med Description and Major Businesses
Table 137. Bio-Med Inactivated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Bio-Med Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Bio-Med Recent Developments
Table 140. Halfkin Bio-Pharmaceuticals Corporation Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 142. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Inactivated Polio Vaccine Distributors List
Table 148. Inactivated Polio Vaccine Customers List
Table 149. Inactivated Polio Vaccine Market Trends
Table 150. Inactivated Polio Vaccine Market Drivers
Table 151. Inactivated Polio Vaccine Market Challenges
Table 152. Inactivated Polio Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Inactivated Polio Vaccine Product Picture
Figure 3. Global Inactivated Polio Vaccine Market Share by Type in 2021 & 2028
Figure 3. Government Product Picture
Figure 4. Private Sector Product Picture
Figure 5. Global Inactivated Polio Vaccine Market Share by Application in 2021 & 2028
Figure 6. Pediatrics
Figure 7. Adults
Figure 8. Inactivated Polio Vaccine Report Years Considered
Figure 9. Global Inactivated Polio Vaccine Sales 2017-2028 (K Units)
Figure 10. Global Inactivated Polio Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Inactivated Polio Vaccine Revenue 2017-2028 (US$ Million)
Figure 12. Global Inactivated Polio Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Inactivated Polio Vaccine Sales Market Share by Region (2017-2022)
Figure 14. Global Inactivated Polio Vaccine Sales Market Share by Region (2023-2028)
Figure 15. North America Inactivated Polio Vaccine Sales YoY (2017-2028) & (K Units)
Figure 16. North America Inactivated Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Inactivated Polio Vaccine Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Inactivated Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Inactivated Polio Vaccine Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Inactivated Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Inactivated Polio Vaccine Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Inactivated Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Inactivated Polio Vaccine Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Inactivated Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Inactivated Polio Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Inactivated Polio Vaccine in the World: Market Share by Inactivated Polio Vaccine Revenue in 2021
Figure 27. Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Inactivated Polio Vaccine Sales Market Share by Type (2017-2028)
Figure 29. Global Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028)
Figure 30. Global Inactivated Polio Vaccine Sales Market Share by Application (2017-2028)
Figure 31. Global Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028)
Figure 32. North America Inactivated Polio Vaccine Sales Market Share by Type (2017-2028)
Figure 33. North America Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028)
Figure 34. North America Inactivated Polio Vaccine Sales Market Share by Application (2017-2028)
Figure 35. North America Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. North America Inactivated Polio Vaccine Sales Share by Country (2017-2028)
Figure 37. North America Inactivated Polio Vaccine Revenue Share by Country (2017-2028)
Figure 38. U.S. Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Inactivated Polio Vaccine Sales Market Share by Type (2017-2028)
Figure 41. Europe Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Inactivated Polio Vaccine Sales Market Share by Application (2017-2028)
Figure 43. Europe Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Inactivated Polio Vaccine Sales Share by Country (2017-2028)
Figure 45. Europe Inactivated Polio Vaccine Revenue Share by Country (2017-2028)
Figure 46. Germany Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. France Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Inactivated Polio Vaccine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Inactivated Polio Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Inactivated Polio Vaccine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Inactivated Polio Vaccine Revenue Share by Region (2017-2028)
Figure 57. China Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. India Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Inactivated Polio Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Latin America Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Inactivated Polio Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Latin America Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Inactivated Polio Vaccine Sales Share by Country (2017-2028)
Figure 72. Latin America Inactivated Polio Vaccine Revenue Share by Country (2017-2028)
Figure 73. Mexico Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Inactivated Polio Vaccine Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Inactivated Polio Vaccine Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Inactivated Polio Vaccine Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Inactivated Polio Vaccine Revenue Share by Country (2017-2028)
Figure 82. Turkey Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Inactivated Polio Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. Inactivated Polio Vaccine Value Chain
Figure 86. Inactivated Polio Vaccine Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Industry Market Size
